nodes	percent_of_prediction	percent_of_DWPC	metapath
Acetaminophen—SLC22A6—Hydrochlorothiazide—nephrolithiasis	0.339	1	CbGbCtD
Acetaminophen—NAT2—urine—nephrolithiasis	0.0438	0.207	CbGeAlD
Acetaminophen—SULT1E1—Cytosolic sulfonation of small molecules—SLC26A1—nephrolithiasis	0.0312	0.0967	CbGpPWpGaD
Acetaminophen—SULT1A1—Cytosolic sulfonation of small molecules—SLC26A1—nephrolithiasis	0.0275	0.0851	CbGpPWpGaD
Acetaminophen—SULT2A1—Cytosolic sulfonation of small molecules—SLC26A1—nephrolithiasis	0.0236	0.0733	CbGpPWpGaD
Acetaminophen—SLC22A6—Organic anion transport—SLC22A12—nephrolithiasis	0.0216	0.0668	CbGpPWpGaD
Acetaminophen—UGT1A1—urine—nephrolithiasis	0.0162	0.0766	CbGeAlD
Acetaminophen—UGT1A10—renal system—nephrolithiasis	0.0115	0.0545	CbGeAlD
Acetaminophen—UGT1A10—kidney—nephrolithiasis	0.0111	0.0527	CbGeAlD
Acetaminophen—TRPV1—Stimuli-sensing channels—CLCN5—nephrolithiasis	0.0111	0.0344	CbGpPWpGaD
Acetaminophen—TRPV1—Stimuli-sensing channels—CLCN4—nephrolithiasis	0.0111	0.0344	CbGpPWpGaD
Acetaminophen—NAT2—renal system—nephrolithiasis	0.0107	0.0506	CbGeAlD
Acetaminophen—SLC22A6—Organic cation/anion/zwitterion transport—SLC22A12—nephrolithiasis	0.01	0.0311	CbGpPWpGaD
Acetaminophen—SULT1E1—Phase II conjugation—SLC26A1—nephrolithiasis	0.00798	0.0247	CbGpPWpGaD
Acetaminophen—SULT1A1—renal system—nephrolithiasis	0.00792	0.0374	CbGeAlD
Acetaminophen—SULT1A1—kidney—nephrolithiasis	0.00765	0.0362	CbGeAlD
Acetaminophen—PTGS2—nephron—nephrolithiasis	0.00741	0.035	CbGeAlD
Acetaminophen—TRPV1—Ion channel transport—CLCN5—nephrolithiasis	0.00725	0.0225	CbGpPWpGaD
Acetaminophen—TRPV1—Ion channel transport—CLCN4—nephrolithiasis	0.00725	0.0225	CbGpPWpGaD
Acetaminophen—CYP1A2—urine—nephrolithiasis	0.00718	0.0339	CbGeAlD
Acetaminophen—SULT1A1—Phase II conjugation—SLC26A1—nephrolithiasis	0.00702	0.0218	CbGpPWpGaD
Acetaminophen—TRPV1—renal system—nephrolithiasis	0.00697	0.0329	CbGeAlD
Acetaminophen—CYP2C9—urine—nephrolithiasis	0.00681	0.0322	CbGeAlD
Acetaminophen—CYP2E1—urine—nephrolithiasis	0.00646	0.0305	CbGeAlD
Acetaminophen—SULT2A1—Phase II conjugation—SLC26A1—nephrolithiasis	0.00605	0.0187	CbGpPWpGaD
Acetaminophen—UGT1A9—renal system—nephrolithiasis	0.00579	0.0273	CbGeAlD
Acetaminophen—NAT2—Phase II conjugation—SLC26A1—nephrolithiasis	0.00577	0.0179	CbGpPWpGaD
Acetaminophen—UGT1A9—kidney—nephrolithiasis	0.00559	0.0264	CbGeAlD
Acetaminophen—UGT2B15—Phase II conjugation—SLC26A1—nephrolithiasis	0.00542	0.0168	CbGpPWpGaD
Acetaminophen—CYP3A4—urine—nephrolithiasis	0.0052	0.0245	CbGeAlD
Acetaminophen—CYP2D6—urine—nephrolithiasis	0.00511	0.0242	CbGeAlD
Acetaminophen—SLC22A6—nephron tubule—nephrolithiasis	0.00471	0.0223	CbGeAlD
Acetaminophen—SULT1E1—Biological oxidations—SLC26A1—nephrolithiasis	0.00467	0.0145	CbGpPWpGaD
Acetaminophen—UGT1A6—Phase II conjugation—SLC26A1—nephrolithiasis	0.00453	0.014	CbGpPWpGaD
Acetaminophen—Coordination abnormal—Hydrochlorothiazide—nephrolithiasis	0.00411	0.0324	CcSEcCtD
Acetaminophen—SULT1A1—Biological oxidations—SLC26A1—nephrolithiasis	0.00411	0.0127	CbGpPWpGaD
Acetaminophen—SLC22A6—cortex of kidney—nephrolithiasis	0.00403	0.0191	CbGeAlD
Acetaminophen—UGT1A1—renal system—nephrolithiasis	0.00397	0.0187	CbGeAlD
Acetaminophen—Wheezing—Hydrochlorothiazide—nephrolithiasis	0.00392	0.0309	CcSEcCtD
Acetaminophen—UGT1A1—kidney—nephrolithiasis	0.00383	0.0181	CbGeAlD
Acetaminophen—Pulmonary oedema—Hydrochlorothiazide—nephrolithiasis	0.0036	0.0283	CcSEcCtD
Acetaminophen—SULT2A1—Biological oxidations—SLC26A1—nephrolithiasis	0.00354	0.011	CbGpPWpGaD
Acetaminophen—NAT2—Biological oxidations—SLC26A1—nephrolithiasis	0.00337	0.0105	CbGpPWpGaD
Acetaminophen—Photosensitivity—Hydrochlorothiazide—nephrolithiasis	0.00334	0.0263	CcSEcCtD
Acetaminophen—CNR1—GPCRs, Other—CHRM3—nephrolithiasis	0.00334	0.0103	CbGpPWpGaD
Acetaminophen—Haemolytic anaemia—Hydrochlorothiazide—nephrolithiasis	0.00325	0.0256	CcSEcCtD
Acetaminophen—CNR1—G alpha (i) signalling events—RGS14—nephrolithiasis	0.0032	0.00992	CbGpPWpGaD
Acetaminophen—UGT2B15—Biological oxidations—SLC26A1—nephrolithiasis	0.00317	0.00983	CbGpPWpGaD
Acetaminophen—Dermatitis exfoliative—Hydrochlorothiazide—nephrolithiasis	0.00311	0.0245	CcSEcCtD
Acetaminophen—UGT1A6—NRF2 pathway—SLC2A9—nephrolithiasis	0.00302	0.00935	CbGpPWpGaD
Acetaminophen—Pain in extremity—Hydrochlorothiazide—nephrolithiasis	0.00293	0.0231	CcSEcCtD
Acetaminophen—Hypokalaemia—Hydrochlorothiazide—nephrolithiasis	0.00267	0.021	CcSEcCtD
Acetaminophen—UGT1A6—Biological oxidations—SLC26A1—nephrolithiasis	0.00265	0.0082	CbGpPWpGaD
Acetaminophen—Aspartate aminotransferase increased—Hydrochlorothiazide—nephrolithiasis	0.00264	0.0208	CcSEcCtD
Acetaminophen—Toxic epidermal necrolysis—Hydrochlorothiazide—nephrolithiasis	0.00264	0.0208	CcSEcCtD
Acetaminophen—Muscular weakness—Hydrochlorothiazide—nephrolithiasis	0.00259	0.0204	CcSEcCtD
Acetaminophen—Abdominal distension—Hydrochlorothiazide—nephrolithiasis	0.00255	0.0201	CcSEcCtD
Acetaminophen—TRPV1—Transmembrane transport of small molecules—CLCN5—nephrolithiasis	0.00252	0.00782	CbGpPWpGaD
Acetaminophen—TRPV1—Transmembrane transport of small molecules—CLCN4—nephrolithiasis	0.00252	0.00782	CbGpPWpGaD
Acetaminophen—Neutropenia—Hydrochlorothiazide—nephrolithiasis	0.00237	0.0187	CcSEcCtD
Acetaminophen—Dysuria—Hydrochlorothiazide—nephrolithiasis	0.00237	0.0187	CcSEcCtD
Acetaminophen—Photosensitivity reaction—Hydrochlorothiazide—nephrolithiasis	0.00231	0.0182	CcSEcCtD
Acetaminophen—Hyperglycaemia—Hydrochlorothiazide—nephrolithiasis	0.00229	0.018	CcSEcCtD
Acetaminophen—TRPV1—Transmembrane transport of small molecules—SLC26A6—nephrolithiasis	0.00225	0.00697	CbGpPWpGaD
Acetaminophen—Stevens-Johnson syndrome—Hydrochlorothiazide—nephrolithiasis	0.00224	0.0177	CcSEcCtD
Acetaminophen—Sweating—Hydrochlorothiazide—nephrolithiasis	0.00217	0.0171	CcSEcCtD
Acetaminophen—Agranulocytosis—Hydrochlorothiazide—nephrolithiasis	0.00211	0.0166	CcSEcCtD
Acetaminophen—TRPV1—Transmembrane transport of small molecules—SLC34A3—nephrolithiasis	0.00206	0.00637	CbGpPWpGaD
Acetaminophen—TRPV1—Transmembrane transport of small molecules—SLC3A1—nephrolithiasis	0.00206	0.00637	CbGpPWpGaD
Acetaminophen—Hepatitis—Hydrochlorothiazide—nephrolithiasis	0.00203	0.016	CcSEcCtD
Acetaminophen—SLC22A6—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC22A12—nephrolithiasis	0.00201	0.00623	CbGpPWpGaD
Acetaminophen—UGT1A1—Phase II conjugation—SLC26A1—nephrolithiasis	0.00201	0.00622	CbGpPWpGaD
Acetaminophen—UGT1A9—Phase II conjugation—SLC26A1—nephrolithiasis	0.00201	0.00622	CbGpPWpGaD
Acetaminophen—Oedema peripheral—Hydrochlorothiazide—nephrolithiasis	0.002	0.0157	CcSEcCtD
Acetaminophen—Erythema multiforme—Hydrochlorothiazide—nephrolithiasis	0.00192	0.0151	CcSEcCtD
Acetaminophen—Flushing—Hydrochlorothiazide—nephrolithiasis	0.00188	0.0148	CcSEcCtD
Acetaminophen—CYP2C8—renal system—nephrolithiasis	0.00188	0.00887	CbGeAlD
Acetaminophen—SLC22A6—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC2A9—nephrolithiasis	0.00187	0.00579	CbGpPWpGaD
Acetaminophen—CYP2C8—kidney—nephrolithiasis	0.00181	0.00857	CbGeAlD
Acetaminophen—Erythema—Hydrochlorothiazide—nephrolithiasis	0.00177	0.0139	CcSEcCtD
Acetaminophen—CYP1A2—renal system—nephrolithiasis	0.00176	0.0083	CbGeAlD
Acetaminophen—CYP2E1—nephron tubule—nephrolithiasis	0.00174	0.00821	CbGeAlD
Acetaminophen—Tension—Hydrochlorothiazide—nephrolithiasis	0.00173	0.0137	CcSEcCtD
Acetaminophen—CYP1A1—renal system—nephrolithiasis	0.00173	0.00818	CbGeAlD
Acetaminophen—Nervousness—Hydrochlorothiazide—nephrolithiasis	0.00172	0.0135	CcSEcCtD
Acetaminophen—Muscle spasms—Hydrochlorothiazide—nephrolithiasis	0.0017	0.0134	CcSEcCtD
Acetaminophen—CYP1A1—kidney—nephrolithiasis	0.00167	0.00791	CbGeAlD
Acetaminophen—Vision blurred—Hydrochlorothiazide—nephrolithiasis	0.00166	0.0131	CcSEcCtD
Acetaminophen—Tremor—Hydrochlorothiazide—nephrolithiasis	0.00165	0.013	CcSEcCtD
Acetaminophen—Ill-defined disorder—Hydrochlorothiazide—nephrolithiasis	0.00164	0.0129	CcSEcCtD
Acetaminophen—Anaemia—Hydrochlorothiazide—nephrolithiasis	0.00163	0.0129	CcSEcCtD
Acetaminophen—Agitation—Hydrochlorothiazide—nephrolithiasis	0.00162	0.0128	CcSEcCtD
Acetaminophen—Angioedema—Hydrochlorothiazide—nephrolithiasis	0.00161	0.0127	CcSEcCtD
Acetaminophen—Malaise—Hydrochlorothiazide—nephrolithiasis	0.00159	0.0126	CcSEcCtD
Acetaminophen—Leukopenia—Hydrochlorothiazide—nephrolithiasis	0.00158	0.0125	CcSEcCtD
Acetaminophen—CYP2E1—renal system—nephrolithiasis	0.00158	0.00746	CbGeAlD
Acetaminophen—Palpitations—Hydrochlorothiazide—nephrolithiasis	0.00156	0.0123	CcSEcCtD
Acetaminophen—TRPV1—Transmembrane transport of small molecules—SLC22A12—nephrolithiasis	0.00156	0.00483	CbGpPWpGaD
Acetaminophen—TRPV1—Transmembrane transport of small molecules—SLC34A1—nephrolithiasis	0.00156	0.00483	CbGpPWpGaD
Acetaminophen—Cough—Hydrochlorothiazide—nephrolithiasis	0.00154	0.0121	CcSEcCtD
Acetaminophen—CYP2E1—kidney—nephrolithiasis	0.00153	0.00722	CbGeAlD
Acetaminophen—PTGS1—renal system—nephrolithiasis	0.00152	0.00719	CbGeAlD
Acetaminophen—Chest pain—Hydrochlorothiazide—nephrolithiasis	0.0015	0.0118	CcSEcCtD
Acetaminophen—Anxiety—Hydrochlorothiazide—nephrolithiasis	0.0015	0.0118	CcSEcCtD
Acetaminophen—CYP2E1—cortex of kidney—nephrolithiasis	0.00149	0.00703	CbGeAlD
Acetaminophen—Discomfort—Hydrochlorothiazide—nephrolithiasis	0.00149	0.0117	CcSEcCtD
Acetaminophen—PTGS1—kidney—nephrolithiasis	0.00147	0.00695	CbGeAlD
Acetaminophen—Dry mouth—Hydrochlorothiazide—nephrolithiasis	0.00147	0.0116	CcSEcCtD
Acetaminophen—PTGS2—renal system—nephrolithiasis	0.00145	0.00687	CbGeAlD
Acetaminophen—Confusional state—Hydrochlorothiazide—nephrolithiasis	0.00145	0.0115	CcSEcCtD
Acetaminophen—CNR1—GPCRs, Class A Rhodopsin-like—CHRM3—nephrolithiasis	0.00145	0.0045	CbGpPWpGaD
Acetaminophen—TRPV1—Transmembrane transport of small molecules—SLC26A1—nephrolithiasis	0.00145	0.00449	CbGpPWpGaD
Acetaminophen—TRPV1—Transmembrane transport of small molecules—SLC2A9—nephrolithiasis	0.00145	0.00449	CbGpPWpGaD
Acetaminophen—Anaphylactic shock—Hydrochlorothiazide—nephrolithiasis	0.00144	0.0114	CcSEcCtD
Acetaminophen—Oedema—Hydrochlorothiazide—nephrolithiasis	0.00144	0.0114	CcSEcCtD
Acetaminophen—Shock—Hydrochlorothiazide—nephrolithiasis	0.00142	0.0112	CcSEcCtD
Acetaminophen—Thrombocytopenia—Hydrochlorothiazide—nephrolithiasis	0.00141	0.0111	CcSEcCtD
Acetaminophen—Tachycardia—Hydrochlorothiazide—nephrolithiasis	0.00141	0.0111	CcSEcCtD
Acetaminophen—PTGS2—kidney—nephrolithiasis	0.00141	0.00664	CbGeAlD
Acetaminophen—Hyperhidrosis—Hydrochlorothiazide—nephrolithiasis	0.00139	0.011	CcSEcCtD
Acetaminophen—Anorexia—Hydrochlorothiazide—nephrolithiasis	0.00137	0.0108	CcSEcCtD
Acetaminophen—Hypotension—Hydrochlorothiazide—nephrolithiasis	0.00135	0.0106	CcSEcCtD
Acetaminophen—UGT1A1—NRF2 pathway—SLC2A9—nephrolithiasis	0.00134	0.00415	CbGpPWpGaD
Acetaminophen—UGT1A9—NRF2 pathway—SLC2A9—nephrolithiasis	0.00134	0.00415	CbGpPWpGaD
Acetaminophen—SLC22A6—SLC-mediated transmembrane transport—SLC26A6—nephrolithiasis	0.00132	0.00409	CbGpPWpGaD
Acetaminophen—Insomnia—Hydrochlorothiazide—nephrolithiasis	0.0013	0.0103	CcSEcCtD
Acetaminophen—TRPV1—Transmembrane transport of small molecules—SLC7A9—nephrolithiasis	0.00129	0.004	CbGpPWpGaD
Acetaminophen—TRPV1—Transmembrane transport of small molecules—ATP6V0A4—nephrolithiasis	0.00129	0.004	CbGpPWpGaD
Acetaminophen—Dyspnoea—Hydrochlorothiazide—nephrolithiasis	0.00128	0.0101	CcSEcCtD
Acetaminophen—Somnolence—Hydrochlorothiazide—nephrolithiasis	0.00128	0.0101	CcSEcCtD
Acetaminophen—CYP3A4—renal system—nephrolithiasis	0.00127	0.00601	CbGeAlD
Acetaminophen—Dyspepsia—Hydrochlorothiazide—nephrolithiasis	0.00127	0.01	CcSEcCtD
Acetaminophen—Decreased appetite—Hydrochlorothiazide—nephrolithiasis	0.00125	0.00987	CcSEcCtD
Acetaminophen—CYP2D6—renal system—nephrolithiasis	0.00125	0.00591	CbGeAlD
Acetaminophen—CNR1—Class A/1 (Rhodopsin-like receptors)—CHRM3—nephrolithiasis	0.00124	0.00385	CbGpPWpGaD
Acetaminophen—Fatigue—Hydrochlorothiazide—nephrolithiasis	0.00124	0.00979	CcSEcCtD
Acetaminophen—Constipation—Hydrochlorothiazide—nephrolithiasis	0.00123	0.00971	CcSEcCtD
Acetaminophen—CYP3A4—kidney—nephrolithiasis	0.00123	0.00581	CbGeAlD
Acetaminophen—CYP2D6—kidney—nephrolithiasis	0.00121	0.00571	CbGeAlD
Acetaminophen—SLC22A6—SLC-mediated transmembrane transport—SLC34A3—nephrolithiasis	0.00121	0.00374	CbGpPWpGaD
Acetaminophen—SLC22A6—SLC-mediated transmembrane transport—SLC3A1—nephrolithiasis	0.00121	0.00374	CbGpPWpGaD
Acetaminophen—Feeling abnormal—Hydrochlorothiazide—nephrolithiasis	0.00119	0.00936	CcSEcCtD
Acetaminophen—Gastrointestinal pain—Hydrochlorothiazide—nephrolithiasis	0.00118	0.00929	CcSEcCtD
Acetaminophen—UGT1A1—Biological oxidations—SLC26A1—nephrolithiasis	0.00117	0.00364	CbGpPWpGaD
Acetaminophen—UGT1A9—Biological oxidations—SLC26A1—nephrolithiasis	0.00117	0.00364	CbGpPWpGaD
Acetaminophen—Urticaria—Hydrochlorothiazide—nephrolithiasis	0.00114	0.00902	CcSEcCtD
Acetaminophen—Abdominal pain—Hydrochlorothiazide—nephrolithiasis	0.00114	0.00898	CcSEcCtD
Acetaminophen—Body temperature increased—Hydrochlorothiazide—nephrolithiasis	0.00114	0.00898	CcSEcCtD
Acetaminophen—CNR1—GPCR downstream signaling—RGS14—nephrolithiasis	0.0011	0.00339	CbGpPWpGaD
Acetaminophen—CNR1—BDNF signaling pathway—SPP1—nephrolithiasis	0.00106	0.00329	CbGpPWpGaD
Acetaminophen—Hypersensitivity—Hydrochlorothiazide—nephrolithiasis	0.00106	0.00837	CcSEcCtD
Acetaminophen—SULT1E1—Metabolism—GRHPR—nephrolithiasis	0.00105	0.00326	CbGpPWpGaD
Acetaminophen—Asthenia—Hydrochlorothiazide—nephrolithiasis	0.00103	0.00815	CcSEcCtD
Acetaminophen—TRPV1—Transmembrane transport of small molecules—AQP1—nephrolithiasis	0.00103	0.0032	CbGpPWpGaD
Acetaminophen—CYP2A6—NRF2 pathway—SLC2A9—nephrolithiasis	0.00103	0.0032	CbGpPWpGaD
Acetaminophen—Pruritus—Hydrochlorothiazide—nephrolithiasis	0.00102	0.00804	CcSEcCtD
Acetaminophen—CNR1—Signaling by GPCR—RGS14—nephrolithiasis	0.000995	0.00308	CbGpPWpGaD
Acetaminophen—ABCB1—nephron tubule—nephrolithiasis	0.00099	0.00468	CbGeAlD
Acetaminophen—Diarrhoea—Hydrochlorothiazide—nephrolithiasis	0.000986	0.00777	CcSEcCtD
Acetaminophen—PTGS1—Biological oxidations—SLC26A1—nephrolithiasis	0.000957	0.00297	CbGpPWpGaD
Acetaminophen—Dizziness—Hydrochlorothiazide—nephrolithiasis	0.000953	0.00751	CcSEcCtD
Acetaminophen—CNR1—GPCR ligand binding—CHRM3—nephrolithiasis	0.000947	0.00293	CbGpPWpGaD
Acetaminophen—SULT1E1—Metabolism—AGXT—nephrolithiasis	0.000939	0.00291	CbGpPWpGaD
Acetaminophen—SULT1A1—Metabolism—GRHPR—nephrolithiasis	0.000927	0.00287	CbGpPWpGaD
Acetaminophen—Vomiting—Hydrochlorothiazide—nephrolithiasis	0.000916	0.00722	CcSEcCtD
Acetaminophen—SLC22A6—SLC-mediated transmembrane transport—SLC34A1—nephrolithiasis	0.000914	0.00283	CbGpPWpGaD
Acetaminophen—SLC22A6—SLC-mediated transmembrane transport—SLC22A12—nephrolithiasis	0.000914	0.00283	CbGpPWpGaD
Acetaminophen—Rash—Hydrochlorothiazide—nephrolithiasis	0.000909	0.00716	CcSEcCtD
Acetaminophen—Dermatitis—Hydrochlorothiazide—nephrolithiasis	0.000908	0.00716	CcSEcCtD
Acetaminophen—CYP2A6—Biological oxidations—SLC26A1—nephrolithiasis	0.000905	0.0028	CbGpPWpGaD
Acetaminophen—Headache—Hydrochlorothiazide—nephrolithiasis	0.000903	0.00712	CcSEcCtD
Acetaminophen—ABCB1—renal system—nephrolithiasis	0.0009	0.00425	CbGeAlD
Acetaminophen—ABCB1—kidney—nephrolithiasis	0.00087	0.00411	CbGeAlD
Acetaminophen—CNR1—GPCR ligand binding—PTH—nephrolithiasis	0.000866	0.00268	CbGpPWpGaD
Acetaminophen—Nausea—Hydrochlorothiazide—nephrolithiasis	0.000856	0.00675	CcSEcCtD
Acetaminophen—SLC22A6—SLC-mediated transmembrane transport—SLC2A9—nephrolithiasis	0.00085	0.00263	CbGpPWpGaD
Acetaminophen—SLC22A6—SLC-mediated transmembrane transport—SLC26A1—nephrolithiasis	0.00085	0.00263	CbGpPWpGaD
Acetaminophen—ABCB1—cortex of kidney—nephrolithiasis	0.000847	0.004	CbGeAlD
Acetaminophen—SULT1A1—Metabolism—AGXT—nephrolithiasis	0.000826	0.00256	CbGpPWpGaD
Acetaminophen—SULT1E1—Metabolism—SLC26A1—nephrolithiasis	0.000798	0.00247	CbGpPWpGaD
Acetaminophen—SULT1E1—Metabolism—APRT—nephrolithiasis	0.000798	0.00247	CbGpPWpGaD
Acetaminophen—SULT2A1—Metabolism—GRHPR—nephrolithiasis	0.000798	0.00247	CbGpPWpGaD
Acetaminophen—NAT2—Metabolism—GRHPR—nephrolithiasis	0.000761	0.00236	CbGpPWpGaD
Acetaminophen—SLC22A6—SLC-mediated transmembrane transport—SLC7A9—nephrolithiasis	0.000757	0.00235	CbGpPWpGaD
Acetaminophen—SLC22A6—Transmembrane transport of small molecules—CLCN4—nephrolithiasis	0.000752	0.00233	CbGpPWpGaD
Acetaminophen—SLC22A6—Transmembrane transport of small molecules—CLCN5—nephrolithiasis	0.000752	0.00233	CbGpPWpGaD
Acetaminophen—CNR1—GPCR downstream signaling—DGKH—nephrolithiasis	0.00074	0.00229	CbGpPWpGaD
Acetaminophen—CYP1A2—Phase II conjugation—SLC26A1—nephrolithiasis	0.000735	0.00228	CbGpPWpGaD
Acetaminophen—PTGS2—Spinal Cord Injury—AQP1—nephrolithiasis	0.000732	0.00227	CbGpPWpGaD
Acetaminophen—UGT2B15—Metabolism—GRHPR—nephrolithiasis	0.000716	0.00222	CbGpPWpGaD
Acetaminophen—CYP2E1—Biological oxidations—SLC26A1—nephrolithiasis	0.000715	0.00222	CbGpPWpGaD
Acetaminophen—SULT2A1—Metabolism—AGXT—nephrolithiasis	0.000711	0.0022	CbGpPWpGaD
Acetaminophen—SULT1A1—Metabolism—APRT—nephrolithiasis	0.000703	0.00218	CbGpPWpGaD
Acetaminophen—SULT1A1—Metabolism—SLC26A1—nephrolithiasis	0.000703	0.00218	CbGpPWpGaD
Acetaminophen—CNR1—Signaling Pathways—ADCY10—nephrolithiasis	0.000691	0.00214	CbGpPWpGaD
Acetaminophen—NAT2—Metabolism—AGXT—nephrolithiasis	0.000679	0.0021	CbGpPWpGaD
Acetaminophen—CYP1A1—Biological oxidations—SLC26A1—nephrolithiasis	0.000674	0.00209	CbGpPWpGaD
Acetaminophen—CNR1—Signaling by GPCR—DGKH—nephrolithiasis	0.000672	0.00208	CbGpPWpGaD
Acetaminophen—SLC22A6—Transmembrane transport of small molecules—SLC26A6—nephrolithiasis	0.00067	0.00208	CbGpPWpGaD
Acetaminophen—UGT2B15—Metabolism—AGXT—nephrolithiasis	0.000638	0.00198	CbGpPWpGaD
Acetaminophen—CYP2C8—Biological oxidations—SLC26A1—nephrolithiasis	0.000618	0.00192	CbGpPWpGaD
Acetaminophen—SLC22A6—Transmembrane transport of small molecules—SLC34A3—nephrolithiasis	0.000613	0.0019	CbGpPWpGaD
Acetaminophen—SLC22A6—Transmembrane transport of small molecules—SLC3A1—nephrolithiasis	0.000613	0.0019	CbGpPWpGaD
Acetaminophen—SULT2A1—Metabolism—SLC26A1—nephrolithiasis	0.000605	0.00187	CbGpPWpGaD
Acetaminophen—SULT2A1—Metabolism—APRT—nephrolithiasis	0.000605	0.00187	CbGpPWpGaD
Acetaminophen—UGT1A6—Metabolism—GRHPR—nephrolithiasis	0.000598	0.00185	CbGpPWpGaD
Acetaminophen—CNR1—Signaling Pathways—RGS14—nephrolithiasis	0.000588	0.00182	CbGpPWpGaD
Acetaminophen—NAT2—Metabolism—SLC26A1—nephrolithiasis	0.000577	0.00179	CbGpPWpGaD
Acetaminophen—NAT2—Metabolism—APRT—nephrolithiasis	0.000577	0.00179	CbGpPWpGaD
Acetaminophen—SULT1E1—Metabolism—AQP1—nephrolithiasis	0.000569	0.00176	CbGpPWpGaD
Acetaminophen—UGT2B15—Metabolism—APRT—nephrolithiasis	0.000543	0.00168	CbGpPWpGaD
Acetaminophen—UGT2B15—Metabolism—SLC26A1—nephrolithiasis	0.000543	0.00168	CbGpPWpGaD
Acetaminophen—CNR1—GPCR downstream signaling—CHRM3—nephrolithiasis	0.000535	0.00166	CbGpPWpGaD
Acetaminophen—UGT1A6—Metabolism—AGXT—nephrolithiasis	0.000533	0.00165	CbGpPWpGaD
Acetaminophen—SULT1E1—Metabolism—CHRM3—nephrolithiasis	0.000514	0.00159	CbGpPWpGaD
Acetaminophen—CYP2D6—Biological oxidations—SLC26A1—nephrolithiasis	0.000508	0.00157	CbGpPWpGaD
Acetaminophen—CYP2C9—Biological oxidations—SLC26A1—nephrolithiasis	0.000503	0.00156	CbGpPWpGaD
Acetaminophen—SULT1A1—Metabolism—AQP1—nephrolithiasis	0.000501	0.00155	CbGpPWpGaD
Acetaminophen—CNR1—GPCR downstream signaling—PTH—nephrolithiasis	0.000489	0.00152	CbGpPWpGaD
Acetaminophen—CNR1—Signaling by GPCR—CHRM3—nephrolithiasis	0.000486	0.00151	CbGpPWpGaD
Acetaminophen—SLC22A6—Transmembrane transport of small molecules—SLC34A1—nephrolithiasis	0.000465	0.00144	CbGpPWpGaD
Acetaminophen—SLC22A6—Transmembrane transport of small molecules—SLC22A12—nephrolithiasis	0.000465	0.00144	CbGpPWpGaD
Acetaminophen—UGT1A6—Metabolism—SLC26A1—nephrolithiasis	0.000453	0.0014	CbGpPWpGaD
Acetaminophen—UGT1A6—Metabolism—APRT—nephrolithiasis	0.000453	0.0014	CbGpPWpGaD
Acetaminophen—SULT1A1—Metabolism—CHRM3—nephrolithiasis	0.000453	0.0014	CbGpPWpGaD
Acetaminophen—CNR1—Signaling by GPCR—PTH—nephrolithiasis	0.000444	0.00138	CbGpPWpGaD
Acetaminophen—SLC22A6—Transmembrane transport of small molecules—SLC26A1—nephrolithiasis	0.000432	0.00134	CbGpPWpGaD
Acetaminophen—SLC22A6—Transmembrane transport of small molecules—SLC2A9—nephrolithiasis	0.000432	0.00134	CbGpPWpGaD
Acetaminophen—SULT2A1—Metabolism—AQP1—nephrolithiasis	0.000431	0.00134	CbGpPWpGaD
Acetaminophen—CYP1A2—Biological oxidations—SLC26A1—nephrolithiasis	0.00043	0.00133	CbGpPWpGaD
Acetaminophen—NAT2—Metabolism—AQP1—nephrolithiasis	0.000411	0.00127	CbGpPWpGaD
Acetaminophen—CNR1—Signaling Pathways—DGKH—nephrolithiasis	0.000397	0.00123	CbGpPWpGaD
Acetaminophen—CNR1—Signaling Pathways—ATP6V0A4—nephrolithiasis	0.000397	0.00123	CbGpPWpGaD
Acetaminophen—SULT2A1—Metabolism—CHRM3—nephrolithiasis	0.00039	0.00121	CbGpPWpGaD
Acetaminophen—UGT2B15—Metabolism—AQP1—nephrolithiasis	0.000387	0.0012	CbGpPWpGaD
Acetaminophen—SLC22A6—Transmembrane transport of small molecules—ATP6V0A4—nephrolithiasis	0.000385	0.00119	CbGpPWpGaD
Acetaminophen—SLC22A6—Transmembrane transport of small molecules—SLC7A9—nephrolithiasis	0.000385	0.00119	CbGpPWpGaD
Acetaminophen—NAT2—Metabolism—CHRM3—nephrolithiasis	0.000372	0.00115	CbGpPWpGaD
Acetaminophen—UGT2B15—Metabolism—CHRM3—nephrolithiasis	0.00035	0.00108	CbGpPWpGaD
Acetaminophen—ABCB1—Transmembrane transport of small molecules—CLCN5—nephrolithiasis	0.000342	0.00106	CbGpPWpGaD
Acetaminophen—ABCB1—Transmembrane transport of small molecules—CLCN4—nephrolithiasis	0.000342	0.00106	CbGpPWpGaD
Acetaminophen—CYP3A4—Biological oxidations—SLC26A1—nephrolithiasis	0.000332	0.00103	CbGpPWpGaD
Acetaminophen—UGT1A6—Metabolism—AQP1—nephrolithiasis	0.000323	0.001	CbGpPWpGaD
Acetaminophen—SLC22A6—Transmembrane transport of small molecules—AQP1—nephrolithiasis	0.000308	0.000953	CbGpPWpGaD
Acetaminophen—ABCB1—Transmembrane transport of small molecules—SLC26A6—nephrolithiasis	0.000305	0.000946	CbGpPWpGaD
Acetaminophen—UGT1A6—Metabolism—CHRM3—nephrolithiasis	0.000292	0.000904	CbGpPWpGaD
Acetaminophen—CNR1—Signaling Pathways—CHRM3—nephrolithiasis	0.000287	0.000889	CbGpPWpGaD
Acetaminophen—ABCB1—Transmembrane transport of small molecules—SLC34A3—nephrolithiasis	0.000279	0.000865	CbGpPWpGaD
Acetaminophen—ABCB1—Transmembrane transport of small molecules—SLC3A1—nephrolithiasis	0.000279	0.000865	CbGpPWpGaD
Acetaminophen—UGT1A1—Metabolism—GRHPR—nephrolithiasis	0.000265	0.000821	CbGpPWpGaD
Acetaminophen—UGT1A9—Metabolism—GRHPR—nephrolithiasis	0.000265	0.000821	CbGpPWpGaD
Acetaminophen—CNR1—Signaling Pathways—PTH—nephrolithiasis	0.000262	0.000813	CbGpPWpGaD
Acetaminophen—UGT1A1—Metabolism—AGXT—nephrolithiasis	0.000236	0.000732	CbGpPWpGaD
Acetaminophen—UGT1A9—Metabolism—AGXT—nephrolithiasis	0.000236	0.000732	CbGpPWpGaD
Acetaminophen—PTGS1—Metabolism—GRHPR—nephrolithiasis	0.000216	0.000669	CbGpPWpGaD
Acetaminophen—ABCB1—Transmembrane transport of small molecules—SLC22A12—nephrolithiasis	0.000212	0.000656	CbGpPWpGaD
Acetaminophen—ABCB1—Transmembrane transport of small molecules—SLC34A1—nephrolithiasis	0.000212	0.000656	CbGpPWpGaD
Acetaminophen—CYP2A6—Metabolism—GRHPR—nephrolithiasis	0.000204	0.000633	CbGpPWpGaD
Acetaminophen—UGT1A1—Metabolism—APRT—nephrolithiasis	0.000201	0.000622	CbGpPWpGaD
Acetaminophen—UGT1A9—Metabolism—SLC26A1—nephrolithiasis	0.000201	0.000622	CbGpPWpGaD
Acetaminophen—UGT1A9—Metabolism—APRT—nephrolithiasis	0.000201	0.000622	CbGpPWpGaD
Acetaminophen—UGT1A1—Metabolism—SLC26A1—nephrolithiasis	0.000201	0.000622	CbGpPWpGaD
Acetaminophen—ABCB1—Transmembrane transport of small molecules—SLC26A1—nephrolithiasis	0.000197	0.000609	CbGpPWpGaD
Acetaminophen—ABCB1—Transmembrane transport of small molecules—SLC2A9—nephrolithiasis	0.000197	0.000609	CbGpPWpGaD
Acetaminophen—PTGS1—Metabolism—AGXT—nephrolithiasis	0.000193	0.000597	CbGpPWpGaD
Acetaminophen—CYP2A6—Metabolism—AGXT—nephrolithiasis	0.000182	0.000564	CbGpPWpGaD
Acetaminophen—ABCB1—Transmembrane transport of small molecules—ATP6V0A4—nephrolithiasis	0.000175	0.000543	CbGpPWpGaD
Acetaminophen—ABCB1—Transmembrane transport of small molecules—SLC7A9—nephrolithiasis	0.000175	0.000543	CbGpPWpGaD
Acetaminophen—PTGS2—Metabolism—GRHPR—nephrolithiasis	0.000171	0.000531	CbGpPWpGaD
Acetaminophen—PTGS1—Metabolism—SLC26A1—nephrolithiasis	0.000164	0.000507	CbGpPWpGaD
Acetaminophen—PTGS1—Metabolism—APRT—nephrolithiasis	0.000164	0.000507	CbGpPWpGaD
Acetaminophen—CYP2E1—Metabolism—GRHPR—nephrolithiasis	0.000161	0.0005	CbGpPWpGaD
Acetaminophen—PTGS2—Disease—SLC26A1—nephrolithiasis	0.000155	0.000481	CbGpPWpGaD
Acetaminophen—CYP2A6—Metabolism—APRT—nephrolithiasis	0.000155	0.00048	CbGpPWpGaD
Acetaminophen—CYP2A6—Metabolism—SLC26A1—nephrolithiasis	0.000155	0.00048	CbGpPWpGaD
Acetaminophen—PTGS2—Metabolism—AGXT—nephrolithiasis	0.000153	0.000474	CbGpPWpGaD
Acetaminophen—CYP1A1—Metabolism—GRHPR—nephrolithiasis	0.000152	0.000472	CbGpPWpGaD
Acetaminophen—CYP2E1—Metabolism—AGXT—nephrolithiasis	0.000144	0.000446	CbGpPWpGaD
Acetaminophen—UGT1A1—Metabolism—AQP1—nephrolithiasis	0.000143	0.000443	CbGpPWpGaD
Acetaminophen—UGT1A9—Metabolism—AQP1—nephrolithiasis	0.000143	0.000443	CbGpPWpGaD
Acetaminophen—ABCB1—Transmembrane transport of small molecules—AQP1—nephrolithiasis	0.00014	0.000434	CbGpPWpGaD
Acetaminophen—CYP2C8—Metabolism—GRHPR—nephrolithiasis	0.00014	0.000432	CbGpPWpGaD
Acetaminophen—PTGS2—Disease—ATP6V0A4—nephrolithiasis	0.000138	0.000429	CbGpPWpGaD
Acetaminophen—CYP1A1—Metabolism—AGXT—nephrolithiasis	0.000136	0.00042	CbGpPWpGaD
Acetaminophen—CNR1—Signaling Pathways—SPP1—nephrolithiasis	0.000132	0.000408	CbGpPWpGaD
Acetaminophen—PTGS2—Metabolism—APRT—nephrolithiasis	0.00013	0.000403	CbGpPWpGaD
Acetaminophen—PTGS2—Metabolism—SLC26A1—nephrolithiasis	0.00013	0.000403	CbGpPWpGaD
Acetaminophen—UGT1A1—Metabolism—CHRM3—nephrolithiasis	0.000129	0.000401	CbGpPWpGaD
Acetaminophen—UGT1A9—Metabolism—CHRM3—nephrolithiasis	0.000129	0.000401	CbGpPWpGaD
Acetaminophen—CYP2C8—Metabolism—AGXT—nephrolithiasis	0.000124	0.000385	CbGpPWpGaD
Acetaminophen—CYP2E1—Metabolism—APRT—nephrolithiasis	0.000122	0.000379	CbGpPWpGaD
Acetaminophen—CYP2E1—Metabolism—SLC26A1—nephrolithiasis	0.000122	0.000379	CbGpPWpGaD
Acetaminophen—ABCB1—Metabolism—GRHPR—nephrolithiasis	0.000122	0.000377	CbGpPWpGaD
Acetaminophen—PTGS1—Metabolism—AQP1—nephrolithiasis	0.000117	0.000361	CbGpPWpGaD
Acetaminophen—CYP1A1—Metabolism—SLC26A1—nephrolithiasis	0.000115	0.000357	CbGpPWpGaD
Acetaminophen—CYP1A1—Metabolism—APRT—nephrolithiasis	0.000115	0.000357	CbGpPWpGaD
Acetaminophen—CYP2D6—Metabolism—GRHPR—nephrolithiasis	0.000115	0.000355	CbGpPWpGaD
Acetaminophen—CYP2C9—Metabolism—GRHPR—nephrolithiasis	0.000114	0.000352	CbGpPWpGaD
Acetaminophen—CYP2A6—Metabolism—AQP1—nephrolithiasis	0.00011	0.000342	CbGpPWpGaD
Acetaminophen—ABCB1—Metabolism—AGXT—nephrolithiasis	0.000108	0.000336	CbGpPWpGaD
Acetaminophen—CYP2C8—Metabolism—SLC26A1—nephrolithiasis	0.000106	0.000328	CbGpPWpGaD
Acetaminophen—CYP2C8—Metabolism—APRT—nephrolithiasis	0.000106	0.000328	CbGpPWpGaD
Acetaminophen—PTGS1—Metabolism—CHRM3—nephrolithiasis	0.000105	0.000327	CbGpPWpGaD
Acetaminophen—CYP2D6—Metabolism—AGXT—nephrolithiasis	0.000102	0.000316	CbGpPWpGaD
Acetaminophen—CYP2C9—Metabolism—AGXT—nephrolithiasis	0.000101	0.000314	CbGpPWpGaD
Acetaminophen—CYP2A6—Metabolism—CHRM3—nephrolithiasis	9.98e-05	0.000309	CbGpPWpGaD
Acetaminophen—CYP1A2—Metabolism—GRHPR—nephrolithiasis	9.7e-05	0.000301	CbGpPWpGaD
Acetaminophen—PTGS2—Metabolism—AQP1—nephrolithiasis	9.26e-05	0.000287	CbGpPWpGaD
Acetaminophen—ABCB1—Metabolism—SLC26A1—nephrolithiasis	9.21e-05	0.000285	CbGpPWpGaD
Acetaminophen—ABCB1—Metabolism—APRT—nephrolithiasis	9.21e-05	0.000285	CbGpPWpGaD
Acetaminophen—CYP2E1—Metabolism—AQP1—nephrolithiasis	8.72e-05	0.00027	CbGpPWpGaD
Acetaminophen—CYP2D6—Metabolism—APRT—nephrolithiasis	8.68e-05	0.000269	CbGpPWpGaD
Acetaminophen—CYP2D6—Metabolism—SLC26A1—nephrolithiasis	8.68e-05	0.000269	CbGpPWpGaD
Acetaminophen—CYP1A2—Metabolism—AGXT—nephrolithiasis	8.65e-05	0.000268	CbGpPWpGaD
Acetaminophen—CYP2C9—Metabolism—SLC26A1—nephrolithiasis	8.61e-05	0.000267	CbGpPWpGaD
Acetaminophen—CYP2C9—Metabolism—APRT—nephrolithiasis	8.61e-05	0.000267	CbGpPWpGaD
Acetaminophen—PTGS2—Metabolism—CHRM3—nephrolithiasis	8.37e-05	0.000259	CbGpPWpGaD
Acetaminophen—CYP1A1—Metabolism—AQP1—nephrolithiasis	8.22e-05	0.000255	CbGpPWpGaD
Acetaminophen—CYP2E1—Metabolism—CHRM3—nephrolithiasis	7.88e-05	0.000244	CbGpPWpGaD
Acetaminophen—CYP2C8—Metabolism—AQP1—nephrolithiasis	7.53e-05	0.000233	CbGpPWpGaD
Acetaminophen—CYP3A4—Metabolism—GRHPR—nephrolithiasis	7.49e-05	0.000232	CbGpPWpGaD
Acetaminophen—CYP1A1—Metabolism—CHRM3—nephrolithiasis	7.43e-05	0.00023	CbGpPWpGaD
Acetaminophen—CYP1A2—Metabolism—SLC26A1—nephrolithiasis	7.35e-05	0.000228	CbGpPWpGaD
Acetaminophen—CYP1A2—Metabolism—APRT—nephrolithiasis	7.35e-05	0.000228	CbGpPWpGaD
Acetaminophen—CYP2C8—Metabolism—CHRM3—nephrolithiasis	6.81e-05	0.000211	CbGpPWpGaD
Acetaminophen—CYP3A4—Metabolism—AGXT—nephrolithiasis	6.67e-05	0.000207	CbGpPWpGaD
Acetaminophen—ABCB1—Metabolism—AQP1—nephrolithiasis	6.56e-05	0.000203	CbGpPWpGaD
Acetaminophen—CYP2D6—Metabolism—AQP1—nephrolithiasis	6.19e-05	0.000192	CbGpPWpGaD
Acetaminophen—CYP2C9—Metabolism—AQP1—nephrolithiasis	6.13e-05	0.00019	CbGpPWpGaD
Acetaminophen—ABCB1—Metabolism—CHRM3—nephrolithiasis	5.94e-05	0.000184	CbGpPWpGaD
Acetaminophen—CYP3A4—Metabolism—SLC26A1—nephrolithiasis	5.68e-05	0.000176	CbGpPWpGaD
Acetaminophen—CYP3A4—Metabolism—APRT—nephrolithiasis	5.68e-05	0.000176	CbGpPWpGaD
Acetaminophen—CYP2D6—Metabolism—CHRM3—nephrolithiasis	5.59e-05	0.000173	CbGpPWpGaD
Acetaminophen—CYP2C9—Metabolism—CHRM3—nephrolithiasis	5.55e-05	0.000172	CbGpPWpGaD
Acetaminophen—CYP1A2—Metabolism—AQP1—nephrolithiasis	5.24e-05	0.000162	CbGpPWpGaD
Acetaminophen—CYP1A2—Metabolism—CHRM3—nephrolithiasis	4.74e-05	0.000147	CbGpPWpGaD
Acetaminophen—CYP3A4—Metabolism—AQP1—nephrolithiasis	4.04e-05	0.000125	CbGpPWpGaD
Acetaminophen—CYP3A4—Metabolism—CHRM3—nephrolithiasis	3.66e-05	0.000113	CbGpPWpGaD
